Blog
HIV, HPV and the limits of “screen-and-treat”: why extensive cervical lesions matter
Cervical cancer kills more African women than any other cancer, and women living with HIV are six times more likely to develop it. Low-...
Doravirine/islatravir for the hardest-to-treat: results in heavily treatment-experienced HIV-1 patients
For people living with HIV-1 who have exhausted their treatment options — those with extensive multidrug resistance and few active drug...
BREATHER Plus: Can adolescents with HIV safely take weekends off treatment?
Daily pill-taking is a heavy burden for the 1.5 million adolescents living with HIV worldwide, nearly 90% of whom are in sub-Saharan Af...